Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults.
Journal: JAMA network open
Published: November 19, 2024
Pharmacokinetics and Safety of Ceftazidime-Avibactam in Neonates and Young Infants: A Phase 2a, Multicenter Prospective Trial.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: October 24, 2024
Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 16, 2024
Correction to: Ceftazidime‑Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta‑analysis.
Journal: Infectious diseases and therapy
Published: August 28, 2024
A phase 1 open label study to assess the human mass balance and metabolite profile of 14C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants.
Journal: Antimicrobial agents and chemotherapy
Published: July 16, 2024
Phase 1 drug-drug interaction study to assess the effect of CYP3A4 inhibition and pan-CYP induction on the pharmacokinetics and safety of fosmanogepix in healthy participants.
Journal: Antimicrobial agents and chemotherapy
Published: May 17, 2024
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants.
Journal: Antimicrobial agents and chemotherapy
Published: March 29, 2024
Efficacy and safety of ceftazidime-avibactam in combination with metronidazole in Japanese patients with complicated intra-abdominal infection: A phase 3, multicentre, open-label study.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: March 26, 2024
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis.
Journal: Infectious diseases and therapy
Published: November 15, 2023
Leveraging real-world data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the management of pediatric hospital-acquired pneumonia.
Journal: American journal of epidemiology
Published: May 31, 2023
Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris: Results from a Phase 2 Trial.
Journal: Antimicrobial agents and chemotherapy
Published: April 06, 2023
Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial.
Journal: The Journal of antimicrobial chemotherapy
Published: April 06, 2023
Last Updated: 09/26/2026